Who owns Calliditas Therap Adr Rep 2 Ord sponsored adr?
- Ticker: CALT
- CUSIP Number: 13124q106
Tip: Access positions for across all investors
Analyze quarterly positions in Calliditas Therap Adr Rep 2 Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Calliditas Therap Adr Rep 2 Ord stock
Who bought or sold Calliditas Therap Adr Rep 2 Ord sponsored adr this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BVF | 750k | $16M | 0% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 51k | $1.1M | 0% | Mar 2024 |
|
Susquehanna International | 33k | $716k | 50% | Mar 2024 |
|
Citadel Advisors | 26k | $556k | 29% | Mar 2024 |
|
Ironwood Investment Management | 26k | $536k | 0% | Mar 2024 |
|
Morgan Stanley | 6.0k | $144k | 157% | Mar 2024 |
|
Federation des caisses Desjardins du Quebec | 4.0k | $84k | 100% | Mar 2024 |
|
Wells Fargo & Company | 3.8k | $79k | 151% | Mar 2024 |
|
Optiver Holding B.V. | 2.5k | $55k | 100% | Mar 2024 |
|
Advisor Group Holdings | 1.1k | $23k | -6% | Mar 2024 |
|
Bank of America Corporation | 1.0k | $22k | 233% | Mar 2024 |
|
Planning Capital Management Corp | 877.00 | $18k | 0% | Mar 2024 |
|
Simplex Trading | 671.00 | $14k | 107% | Mar 2024 |
|
Rhumbline Advisers | 164.00 | $3.5k | 0% | Mar 2024 |
|
Qube Research & Technologies | 72.00 | $1.6k | 0% | Mar 2024 |
|
Tudor Investment Corporation | 65.00 | $1.4k | 100% | Mar 2024 |
|
Missouri Trust & Investment | 35.00 | $735.000000 | 0% | Mar 2024 |
|
Nalls Sherbakoff Group | 18.00 | $464.000400 | -49% | Dec 2023 |
|
Who sold out of Calliditas Therap Adr Rep 2 Ord?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
UBS Group | Dec 2023 | 952.00 | $25k |
Jpmorgan Chase & Co | Dec 2023 | 607.00 | $16k |
Cutler | Dec 2023 | 100.00 | $2.0k |